Xconomy Forum: Boston Biotech Seizes the Momentum

This event is sold out, but we invite you to sign up for the event waitlist here.

Something special is happening in Boston biotech. While many regions struggle to fulfill their biotech dreams, Boston has seized momentum that could make it the world’s No. 1 life sciences cluster for a generation. The mix of great research institutions, small biotech companies, Big Pharma, and medical centers of excellence appears to be taking on a life of its own, attracting more and more life sciences energy to Boston. What has gone right? What’s still missing? What needs to happen next for Boston to make the most of this opportunity? Join Xconomy for a series of in-depth conversations with leading CEOs, venture capitalists, and scientific entrepreneurs who are creating the biotech future in Boston.

Confirmed Speakers:

  • Bob Langer
    • David H. Koch Institute Professor, MIT
  • Christoph Westphal
    • CEO, Verastem
  • Mara Aspinall
    • CEO, Roche/Ventana Medical Systems
  • Bruce Booth
    • Managing Director, Atlas Venture
  • Deborah Dunsire
    • CEO, Millenium: Takeda
  • Jeff Leiden
    • CEO, Vertex Pharmaceuticals
  • Mike Pellini
    • CEO, Foundation Medicine
  • Alfred Sandrock
    • Chief Medical Officer, Biogen Idec
  • David Schenkein
    • CEO, Agios Pharmaceuticals
  • Bob Tepper
    • Partner, Third Rock Ventures
  • Luke Timmerman
    • National Biotechnology Editor, Xconomy

Follow us on Twitter:




Registration & Networking: 12:30 – 1:30 pm

Program: 1:30 – 5:30 pm

Networking reception: 5:30 – 6:30 pm

Full agenda here

Registration Information

Regular Registration: $325 (sold out)

Startup Special: $175 (sold out)

At the Door: $375

Register Now

Biogen Idec
 Alexandria Real Estate Equities; Comcast Business; Cubist Pharmaceuticals; Guard Dog Brand Development; Halloran Consulting Group; MFA - Moody, Famiglietti & Andrionico; Nutter McClennen & Fish